WNT Pathway clinical trials at UCSF
1 research study open to eligible people
The WNT pathway includes proteins crucial for cell communication and growth. UCSF investigates FOG-001 to determine its safety and potential impact on advanced cancer in patients. This study targets cancer that has moved beyond its original site.
Showing trials for
FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations
Last updated: